Illumina’s ‘inevitable’ split from Grail likely by mid-2024, analysts say
Dive Brief: The European Commission is “almost certain” to force Illumina’s divestment of Grail, a move that could happen in the first half of 2024, analysts
Dive Brief: The European Commission is “almost certain” to force Illumina’s divestment of Grail, a move that could happen in the first half of 2024, analysts
Dive Brief: The Federal Trade Commission has intervened in a legal case to correct what it called “erroneous assertions and mistaken legal points” made by
Dive Brief: The European Society of Hypertension (ESH) updated its guidelines in late June on the treatment of high blood pressure to offer some support
LONDON, July 05, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental
The U.S. Food and Drug Administration (FDA) has published a draft guidance outlining considerations for researchers investigating the use of psychedelic drugs for potential medical
Illinois adult-use cannabis sales in June were up a bit sequentially to $136.4 million, a gain of 2.7% despite one less day than May. The gain was
Cancer cells with extra chromosomes depend on those chromosomes for tumor growth, a new Yale study reveals, and eliminating them prevents the cells from forming
Mental health issues affect a significant percentage of children and adolescents worldwide, with behavior problems being among the most prevalent. Behavior problems in adolescence can
Psilocybin-based treatment combined with therapy may provide more cost-effective solution to treating Major Depressive Disorder than methods such as CBT It was also found to
Researchers at Johns Hopkins Medicine, in collaboration with researchers at the National Institutes of Health, report that two new studies in mice with a humanized